Philip P Roessler1,2, Bernhard Pfister1, Markus Gesslein3, Jens Figiel4, Thomas J Heyse1, Christian Colcuc1, Olaf Lorbach5, Turgay Efe6, Karl F Schüttler1. 1. Department of Orthopaedics and Rheumatology, University Hospital Marburg, Baldingerstrasse, 35043, Marburg, Germany. 2. Department of Orthopaedics and Traumatology, University Hospital Bonn, Bonn, Germany. 3. Department of Trauma and Orthopaedic Surgery, Paracelsus Medical University, Nürnberg, Germany. 4. Department of Radiology, University Hospital Marburg, Marburg, Germany. 5. Department of Orthopaedic Surgery, Saarland University, Homburg, Saar, Germany. 6. Department of Orthopaedics and Rheumatology, University Hospital Marburg, Baldingerstrasse, 35043, Marburg, Germany. efet@med.uni-marburg.de.
Abstract
PURPOSE: Although there are various new scaffold-based techniques for cartilage regeneration it remains unclear up to which defect size they can be used. The present study reports of a cell-free collagen type I gel matrix for the treatment of large cartilage defects of the knee after a two-year follow-up. METHODS: Twenty-eight patients with a mean cartilage defect size of 3.71 ± 1.93 cm² were treated with a cell-free collagen type I gel matrix (CaReS-1S®, Arthro Kinetics AG, Krems/Donau, Austria) via a mini-arthrotomy. Clinical outcome was assessed preoperatively and six weeks as well as six, 12 and 24 months after surgery using various clinical outcome scores (IKDC, Tegner, KOOS, VAS). Cartilage regeneration was evaluated via MRI using the MOCART score. RESULTS: Seventeen male and 11 female patients with a mean age of 34.6 years were included in this study. Significant pain reduction (VAS) could be noted after six weeks already. Patient activity (IKDC, Tegner) could be significantly improved from 12 months on and nearly reached reported pre-operative values. All subject categories of the KOOS except for symptom (swelling) showed significant improvements throughout the study. Constant significant improvements of the mean MOCART score were observed from 12 months on. MR images did not yield any signs of infection or synovitis. After 24 months a complete defect filling could be noted in 24 out of 28 cases with a mainly smooth surface, complete integration of the border zone and homogenous structure of the repaired tissue. CONCLUSION: Cell-free collagen type I matrices appear to be a safe and suitable treatment option even for large cartilage defects of the knee. Results of this study were comparable to the better-established findings for small cartilage defects. Mid- and long-term results will be needed to see if clinical and MR-tomographic outcome can be maintained beyond 24 months.
PURPOSE: Although there are various new scaffold-based techniques for cartilage regeneration it remains unclear up to which defect size they can be used. The present study reports of a cell-free collagen type I gel matrix for the treatment of large cartilage defects of the knee after a two-year follow-up. METHODS: Twenty-eight patients with a mean cartilage defect size of 3.71 ± 1.93 cm² were treated with a cell-free collagen type I gel matrix (CaReS-1S®, Arthro Kinetics AG, Krems/Donau, Austria) via a mini-arthrotomy. Clinical outcome was assessed preoperatively and six weeks as well as six, 12 and 24 months after surgery using various clinical outcome scores (IKDC, Tegner, KOOS, VAS). Cartilage regeneration was evaluated via MRI using the MOCART score. RESULTS: Seventeen male and 11 female patients with a mean age of 34.6 years were included in this study. Significant pain reduction (VAS) could be noted after six weeks already. Patient activity (IKDC, Tegner) could be significantly improved from 12 months on and nearly reached reported pre-operative values. All subject categories of the KOOS except for symptom (swelling) showed significant improvements throughout the study. Constant significant improvements of the mean MOCART score were observed from 12 months on. MR images did not yield any signs of infection or synovitis. After 24 months a complete defect filling could be noted in 24 out of 28 cases with a mainly smooth surface, complete integration of the border zone and homogenous structure of the repaired tissue. CONCLUSION: Cell-free collagen type I matrices appear to be a safe and suitable treatment option even for large cartilage defects of the knee. Results of this study were comparable to the better-established findings for small cartilage defects. Mid- and long-term results will be needed to see if clinical and MR-tomographic outcome can be maintained beyond 24 months.
Entities:
Keywords:
Cartilage repair; Cell-free collagen type I; Clinical outcome; Large cartilage defects; MRI; Short-term results
Authors: Lukas Zak; Christian Albrecht; Barbara Wondrasch; Harald Widhalm; György Vekszler; Siegfried Trattnig; Stefan Marlovits; Silke Aldrian Journal: Am J Sports Med Date: 2014-05-09 Impact factor: 6.202
Authors: Philipp Niemeyer; Gian Salzmann; Matthias Feucht; Jan Pestka; Stella Porichis; Peter Ogon; Norbert Südkamp; Hagen Schmal Journal: Int Orthop Date: 2014-05-17 Impact factor: 3.075
Authors: Alfred Hochrein; Wolfgang Zinser; Gunter Spahn; Peter Angele; Ingo Löer; Dirk Albrecht; Philipp Niemeyer Journal: Int Orthop Date: 2018-08-30 Impact factor: 3.075
Authors: Markus L Schwarz; Gregor Reisig; Andy Schütte; Kristianna Becker; Susanne Serba; Elmar Forsch; Steffen Thier; Stefan Fickert; Tamara Lenz; Christel Weiß; Svetlana Hetjens; Frederic Bludau; Friederike Bothe; Wiltrud Richter; Barbara Schneider-Wald Journal: PLoS One Date: 2019-12-26 Impact factor: 3.240